Table 9.6e

Immunosuppression Use for Maintenance

		Year of Transplant
		2000	2001	2002	2003	2004	2005	2006	2007	2008	2009
Functioning Graft at Discharge		4,324	4,573	4,778	5,121	5,623	5,865	6,127	6,000	5,880	5,920
With Immunosuppression Info		4,310	4,567	4,775	5,116	5,595	5,796	6,062	5,965	5,840	5,909
Corticosteroids	Any in Category	91.9%	90.2%	90.4%	82.4%	80.6%	78.9%	78.4%	76.1%	80.2%	81.3%
Corticosteroids	Steroids	91.9%	90.2%	90.4%	82.4%	80.6%	78.9%	78.4%	76.1%	80.2%	81.3%
Cyclosporine	Any in Category	18.5%	11.9%	10.2%	8.7%	8.1%	7.0%	6.7%	7.1%	7.0%	7.0%
	Cyclosporin	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.0%	0.1%
	Sandimmmune	3.1%	1.3%	1.1%	0.4%	0.5%	0.6%	0.8%	0.9%	1.1%	0.8%
	Neoral	15.3%	9.7%	7.4%	7.4%	6.6%	5.6%	4.3%	5.0%	4.6%	4.9%
	Gengraf	0.1%	0.6%	1.5%	0.8%	0.8%	0.6%	1.0%	0.8%	1.0%	0.9%
	Eon	0.0%	0.4%	0.2%	0.1%	0.2%	0.1%	0.5%	0.3%	0.2%	0.2%
Tacrolimus	Any in Category	76.6%	83.1%	86.8%	88.8%	88.7%	90.8%	91.4%	91.7%	91.2%	89.2%
	Tacrolimus	76.6%	83.1%	86.8%	88.8%	88.7%	90.8%	91.3%	90.8%	90.6%	88.8%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	0.5%	0.4%
Antimetabolites	Any in Category	48.3%	50.8%	51.6%	57.3%	58.3%	61.4%	69.2%	72.8%	77.2%	75.5%
	Mycophenolate Mofetil	43.2%	47.7%	48.1%	54.1%	55.7%	58.5%	65.1%	67.3%	71.5%	66.2%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.4%	2.1%	3.7%	4.9%	5.3%	8.1%
	Azathioprine	5.0%	3.0%	3.5%	3.2%	2.1%	0.7%	0.4%	0.6%	0.4%	1.2%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Cytoxan	0.0%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	9.4%	9.9%	6.6%	4.4%	5.0%	4.0%	3.7%	2.5%	2.2%	2.4%
	Sirolimus	9.4%	9.9%	6.6%	4.4%	5.0%	4.0%	3.7%	2.5%	2.2%	2.1%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%